Chris Yates - Abingdon Health CEO Director

ABDX Stock   7.00  0.25  3.45%   

Insider

Chris Yates is CEO Director of Abingdon Health Plc
Age 50
Address York Biotech Campus, York, United Kingdom, YO41 1LZ
Phone44 19 0440 6050
Webhttps://www.abingdonhealth.com

Abingdon Health Management Efficiency

The company has return on total asset (ROA) of (0.1793) % which means that it has lost $0.1793 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4869) %, meaning that it generated substantial loss on money invested by shareholders. Abingdon Health's management efficiency ratios could be used to measure how well Abingdon Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Abingdon Health's Total Assets are comparatively stable compared to the past year. Intangible Assets is likely to gain to about 922.9 K in 2024, whereas Total Current Assets are likely to drop slightly above 3.5 M in 2024.

Similar Executives

Found 8 records

INSIDER Age

Mahindra KumarState Bank of
N/A
Siddhartha SenguptaState Bank of
65
Challa SettyState Bank of
59
Ashwini TewariState Bank of
57
Sureddi RaoState Bank of
N/A
Prabodh ParikhState Bank of
N/A
Charanjit AttraState Bank of
N/A
Swaminathan JanakiramanState Bank of
60
Abingdon Health Plc (ABDX) is traded on London Exchange in UK and employs 84 people. Abingdon Health is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Abingdon Health Plc Leadership Team

Elected by the shareholders, the Abingdon Health's board of directors comprises two types of representatives: Abingdon Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abingdon. The board's role is to monitor Abingdon Health's management team and ensure that shareholders' interests are well served. Abingdon Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abingdon Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Chris Yates, CEO Director
Mark Jones, Chief Officer
Melanie Ross, Company CFO
Nina Garrett, Head Devel
Oliver Gardner, Chief Officer
Laura Towse, Group Controller
Christopher Hand, Executive Chairman
Brenda Hogan, HR Director

Abingdon Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Abingdon Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Abingdon Stock Analysis

When running Abingdon Health's price analysis, check to measure Abingdon Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abingdon Health is operating at the current time. Most of Abingdon Health's value examination focuses on studying past and present price action to predict the probability of Abingdon Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abingdon Health's price. Additionally, you may evaluate how the addition of Abingdon Health to your portfolios can decrease your overall portfolio volatility.